JournalsHub
.online
Find My Journal
AJ

Anthony M. Joshua

Garvan Institute of Medical Research AU

ORCID 0000-0001-5159-4580
765
Publications
30,968
Citations
70
H-Index
224
i10-Index
4.48
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

761 total

[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

Michael S. Hofman, Louise Emmett, Shahneen Sandhu, Amir Iravani, Anthony M. Joshua et al. - The Lancet, 2021
Cited by 1,018 OpenAlex

Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma PDF

Paul Nathan, Jessica C. Hassel, Piotr Rutkowski, Jean‐François Baurain, Marcus O. Butler et al. - New England Journal of Medicine, 2021
Cited by 833 OpenAlex

Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer

Ian D. Davis, Andrew Martin, Martin R. Stockler, Stephen Begbie, Kim N. et al. - New England Journal of Medicine, 2019
Cited by 1,555 OpenAlex

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001 PDF

Omid Hamid, Caroline Robert, Adil Daud, F. Stephen Hodi, Wen‐Jen Hwu et al. - Annals of Oncology, 2019
Cited by 930 OpenAlex

Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab PDF

Richard W. Joseph, Jeroen Elassaiss‐Schaap, Richard Kefford, Wen-Jen Hwu, Jedd D. Wolchok et al. - Clinical Cancer Research, 2018
Cited by 305 OpenAlex

Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma PDF

Caroline Robert, Antoni Ribas, Omid Hamid, Adil Daud, Jedd D. Wolchok et al. - Journal of Clinical Oncology, 2017
Cited by 478 OpenAlex

Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma PDF

Antoni Ribas, Omid Hamid, Adil Daud, F. Stephen Hodi, Jedd D. Wolchok et al. - JAMA, 2016
Cited by 1,054 OpenAlex

Evaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab PDF

F. Stephen Hodi, Wen-Jen Hwu, Richard Kefford, Jeffrey S. Weber, Adil Daud et al. - Journal of Clinical Oncology, 2016
Cited by 743 OpenAlex

Programmed Death-Ligand 1 Expression and Response to the Anti–Programmed Death 1 Antibody Pembrolizumab in Melanoma PDF

Adil Daud, Jedd D. Wolchok, Caroline Robert, Wen-Jen Hwu, Jeffrey S. Weber et al. - Journal of Clinical Oncology, 2016
Cited by 669 OpenAlex

Enzalutamide in Metastatic Prostate Cancer before Chemotherapy PDF

Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf, Yohann Loriot, Cora N. Sternberg et al. - New England Journal of Medicine, 2014
Cited by 3,005 OpenAlex

Research Topics

Prostate Cancer Treatment and Research (331) Cancer Immunotherapy and Biomarkers (160) Radiopharmaceutical Chemistry and Applications (124) Cancer, Lipids, and Metabolism (100) Cancer Genomics and Diagnostics (95)

Affiliations

Northside Hospital
US 2015 - 2015
Université Paris-Sud
FR 2017 - 2017
Ontario Institute for Cancer Research
CA 2013 - 2006
BC Cancer Agency
CA 2012 - 2012
Mount Sinai Hospital
CA 2015 - 2015

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now